Digestive disorders in Parkinson's disease: Dysphagia and sialorrhea;Trastornos digestivos en la enfermedad de Parkinson: Disfagia y sialorrea

Revista de Neurologia

Volumn 50, Issue SUPPL. 2, 2010, Pages

  González Fernández, Jimena ^a   Prieto Albin, Rosa ^a   Velasco Palacios, Leticia ^a   Jorge Roldán, Sandra ^a   Cubo Delgado, Esther ^a  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Botulinum toxin; Dysphagia; Non motor symptoms; Parkinson's disease; Parkinsonism; Sialorrhea

Indexed keywords

BOTULINUM TOXIN; BROMHEXINE; CLONAZEPAM; PIRENPERONE;

ARTICLE; COMORBIDITY; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPHAGIA; EVALUATION; HUMAN; HYPERSALIVATION; PARKINSON DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; SPEECH THERAPY;

ANTIPARKINSON AGENTS; BOTULINUM TOXINS; DEGLUTITION DISORDERS; HUMANS; PARKINSON DISEASE; SIALORRHEA;

EID: 77949526189     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Linazasoro G. Complicaciones no motoras en la enfermedad de Parkinson. In Grandas F, Obeso JA, Tolosa E, eds. Tratado sobre la enfermedad de Parkinson. Madrid: Luzán Ediciones; 2004. p. 193-206.
2. Schindler JS, Kelly JH. Swallowing disorders in the elderly. Laringoscope 2002; 112: 589-602.
3. González-Fernández M, Daniels SK. Dysphagia in stroke and neurologic disease. Phys Med Rehabil Clin N Am 2008; 19: 867-88.
4. Pfeiffer RF, Bodis-Wollner I. Parkinson's disease and nonmotor dysfunction. Totowa, NJ: Humana Press; 2005.
5. Stroudley J, Walsh M. Radiological assessment of dysphagia in Parkinson's disease. Br J Radiol 1991; 64: 890-3.
6. Chaudhuri KR, Martínez-Martín P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed Nonmotor Symptoms Questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-23.
7. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martínez-Martín P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-70.
8. Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, et al. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation. Critique and recommendations to Movement Disorders Task Force on Rating Scales for Parkinson's disease. Mov Disord 2009; 15: 635-46.
9. Andersen LI, Madsen PV, Dalgaard P, Jensen G. Validity of clinical symptoms in benign esophageal disease, assessed by questionnaire. Acta Med Scand 1987; 221: 171-7.
10. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia 2000; 15: 115-21.
11. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988; 3: 73-8.
12. Marks L, Weinreich J. Drooling in Parkinson's disease: a novel tool for assessment of swallow frequency. Int J Lang Commun Disord 2001; 36 (Suppl): 288-91.
13. Pérez-Lloret S, Piran-Arce G, Rossi M, Caivano-Nemet ML, Salsamendi P, Merello M. Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease. Mov Disord 2007; 22: 107-11.
14. Melo A, Rodrigues B, Nóbrega AC. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. J Am Geriatr Soc 2009; 57: 180.
15. Albanese A, Bentivoglio A. Toxina botulínica en los trastornos del movimiento. In Jankovic J, Tolosa E, eds. Enfermedad de Parkinson y trastornos del movimiento. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 605-19.
16. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling. J Neurol 2009; 256: 563-7.
17. Rønning OM, Stavem K. Transdermal scopolamine to reduce salivation and possibly aspiration after stroke. J Stroke Cerebrovasc Dis 2008; 17: 328-9.
18. Tscheng DZ. Sialorrhea, therapeutic drug options. Ann Pharmacother 2002; 36: 1785-90.
19. Lee SY, Seo HG, Paik NJ. Botulinum toxin injection for dysphagia: a blinded retrospective videofluoroscopic swallowing study analysis. Am J Phys Med Rehabil 2009; 88: 491-4.
20. Ehler E, Geier P, Vyhnálek P, Hájek J, Sákra L. Dysphagia in patients with disorders of the nervous system - comparison of a nasogastric tube with percutaneous endoscopic gastrostomy. Rozhl Chir 2002; 81: 316-9.
21. Born LJ, Harned RH, Rikkers LF, Pfeiffer RF, Quigley EM. Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy. Mov Disord 1996; 11: 53-8.